2021
DOI: 10.1016/j.ejim.2020.10.010
|View full text |Cite
|
Sign up to set email alerts
|

Disease course in patients with systemic autoimmune diseases: insights on the safety of immunosuppression during the SARS-CoV-2 outbreak in Italy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 7 publications
0
1
0
Order By: Relevance
“…In the sub-analysis specifically focused on the journals with an important number of Italian contributions, we found that COVID-19-related papers from Italy (defined as first and/or the corresponding author from Italy) accounted for 71% (50/70) and 100% (24/24) in the EJIM and JCM, respectively. The original contributions published on EJIM 6,13–40 (29/70 = 41.4%) and JCM 41–50 (10/24 = 41.6%) constituted a substantial number of the COVID-19-related papers published in these journals: higher than what was published in the other analyzed journals (Fig. 5).…”
Section: Resultsmentioning
confidence: 99%
“…In the sub-analysis specifically focused on the journals with an important number of Italian contributions, we found that COVID-19-related papers from Italy (defined as first and/or the corresponding author from Italy) accounted for 71% (50/70) and 100% (24/24) in the EJIM and JCM, respectively. The original contributions published on EJIM 6,13–40 (29/70 = 41.4%) and JCM 41–50 (10/24 = 41.6%) constituted a substantial number of the COVID-19-related papers published in these journals: higher than what was published in the other analyzed journals (Fig. 5).…”
Section: Resultsmentioning
confidence: 99%